Literature DB >> 8604728

Five-year follow-up of the Fluorouracil Filtering Surgery Study. The Fluorouracil Filtering Surgery Study Group.

.   

Abstract

PURPOSE: To determine the efficacy and safety of subconjunctival 5- fluorouracil injections after trabeculectomy in patients with poor prognoses, to determine risk factors for surgical failure and to examine the relationship of intraocular pressure and visual function.
METHODS: In this multicenter clinical trial, 213 patients with previous cataract surgery or previous failed filtering surgery were randomly assigned to receive either trabeculectomy alone or trabeculectomy with postoperative subconjunctival 5-fluorouracil injections. Measurements of intraocular pressure, visual acuity, and visual fields were performed throughout the five years, with the clinician masked to the treatment group. Failure was defined as a reoperation to control intraocular pressure or an intraocular pressure greater than 21 mm Hg at or after the first-year examination.
RESULTS: Fifty-four (51%) of the 105 eyes in the 5-fluorouracil group and 80 (74%) of the 108 eyes in the standard filtering surgery group were classified as failures (P < .001, Mantel-Cox survival analysis). Risk factors for failure include high intraocular pressure, a short time interval after the last procedure involving a conjunctival incision, the number of procedures with conjunctival incisions, and Hispanic ethnicity. Patients in both treatment groups with controlled intraocular pressures were more likely to maintain visual acuity. Patients in the 5-fluorouracil group had a higher risk of late-onset bleb leaks (9% nine of 105) than those in the standard filtering surgery group (2% two of 108) (P = .032, Fisher's exact test).
CONCLUSIONS: We recommend the use of subconjunctival 5-fluorouracil after trabeculectomy in eyes after previous cataract surgery or unsuccessful filtering surgery, but caution against its routine use in patients with good prognoses.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8604728     DOI: 10.1016/s0002-9394(14)70431-3

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  70 in total

1.  Towards better treatment of glaucoma.

Authors:  P T Khaw; M F Cordeiro; M F Cordiero
Journal:  BMJ       Date:  2000-06-17

2.  Comparison of trabeculectomy and trabeculectomy with amniotic membrane transplantation in the same patient with bilateral glaucoma.

Authors:  Qing-Shan Ji; Bing Qi; Lian Liu; Wei Lao; Zhi-Hao Yang; Gui-Fang Wang; Guo-Cheng Yu; Jing-Xiang Zhong
Journal:  Int J Ophthalmol       Date:  2013-08-18       Impact factor: 1.779

3.  Trypan blue identifies antimetabolite treatment area in trabeculectomy.

Authors:  P R Healey; J G Crowston
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

4.  Anterior chamber paracentesis in patients with acute elevation of intraocular pressure.

Authors:  Stéphane Arnavielle; Catherine Creuzot-Garcher; Alain M Bron
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-11-17       Impact factor: 3.117

5.  Decorin and suramin inhibit ocular fibroblast collagen production.

Authors:  H Mietz; P Chévez-Barrios; M W Lieberman; M Wendt; R Gross; S F Basinger
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-06       Impact factor: 3.117

Review 6.  Aqueous shunts for glaucoma.

Authors:  D S Minckler; S S Vedula; T J Li; M C Mathew; R S Ayyala; B A Francis
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

7.  Three-year treatment outcomes in the Ahmed Baerveldt comparison study.

Authors:  Keith Barton; William J Feuer; Donald L Budenz; Joyce Schiffman; Vital P Costa; David G Godfrey; Yvonne M Buys
Journal:  Ophthalmology       Date:  2014-04-24       Impact factor: 12.079

8.  Subconjunctival bevacizumab as an adjuvant in first-time filtration surgery for patients with primary glaucomas.

Authors:  Luis Gustavo Biteli; Tiago Santos Prata
Journal:  Int Ophthalmol       Date:  2013-02-07       Impact factor: 2.031

9.  A sequential, multiple-treatment, targeted approach to reduce wound healing and failure of glaucoma filtration surgery in a rabbit model (an American Ophthalmological Society thesis).

Authors:  Mark Brian Sherwood
Journal:  Trans Am Ophthalmol Soc       Date:  2006

10.  Inflammatory molecules in aqueous humour and on ocular surface and glaucoma surgery outcome.

Authors:  Barbara Cvenkel; Andreja Natasa Kopitar; Alojz Ihan
Journal:  Mediators Inflamm       Date:  2010-05-05       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.